Evolent Health (EVH) Competitors

Evolent Health logo
$4.49 -0.19 (-3.96%)
Closing price 03:59 PM Eastern
Extended Trading
$4.54 +0.05 (+1.11%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EVH vs. ATHM, TIC, FLYW, STGW, and CNXC

Should you buy Evolent Health stock or one of its competitors? MarketBeat compares Evolent Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Evolent Health include Autohome (ATHM), TIC Solutions (TIC), Flywire (FLYW), Stagwell (STGW), and Concentrix (CNXC). These companies are all part of the "business services" industry.

How does Evolent Health compare to Autohome?

Evolent Health (NYSE:EVH) and Autohome (NYSE:ATHM) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

Autohome has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Autohome, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evolent Health$1.88B0.27-$534.51M-$4.76N/A
Autohome$922.63M2.26$225.19M$1.3113.83

Evolent Health has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market. Comparatively, Autohome has a beta of 0.23, suggesting that its stock price is 77% less volatile than the broader market.

Evolent Health currently has a consensus target price of $6.08, indicating a potential upside of 35.49%. Autohome has a consensus target price of $17.15, indicating a potential downside of 5.35%. Given Evolent Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Evolent Health is more favorable than Autohome.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evolent Health
1 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.71
Autohome
2 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.60

Autohome has a net margin of 17.91% compared to Evolent Health's net margin of -26.29%. Autohome's return on equity of 5.01% beat Evolent Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Evolent Health-26.29% 0.36% 0.10%
Autohome 17.91%5.01%4.01%

In the previous week, Evolent Health had 2 more articles in the media than Autohome. MarketBeat recorded 3 mentions for Evolent Health and 1 mentions for Autohome. Evolent Health's average media sentiment score of 0.25 beat Autohome's score of -0.07 indicating that Evolent Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evolent Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Autohome
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

63.1% of Autohome shares are held by institutional investors. 1.5% of Evolent Health shares are held by insiders. Comparatively, 5.7% of Autohome shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Autohome beats Evolent Health on 9 of the 16 factors compared between the two stocks.

How does Evolent Health compare to TIC Solutions?

Evolent Health (NYSE:EVH) and TIC Solutions (NYSE:TIC) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership.

Evolent Health presently has a consensus price target of $6.08, suggesting a potential upside of 35.49%. TIC Solutions has a consensus price target of $11.50, suggesting a potential upside of 36.18%. Given TIC Solutions' higher possible upside, analysts plainly believe TIC Solutions is more favorable than Evolent Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evolent Health
1 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.71
TIC Solutions
3 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.86

Evolent Health has a beta of 0.84, indicating that its stock price is 16% less volatile than the broader market. Comparatively, TIC Solutions has a beta of 2.9, indicating that its stock price is 190% more volatile than the broader market.

TIC Solutions has lower revenue, but higher earnings than Evolent Health. TIC Solutions is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evolent Health$1.88B0.27-$534.51M-$4.76N/A
TIC Solutions$1.53B1.22-$87.12M-$0.52N/A

TIC Solutions has a net margin of -5.77% compared to Evolent Health's net margin of -26.29%. Evolent Health's return on equity of 0.36% beat TIC Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Evolent Health-26.29% 0.36% 0.10%
TIC Solutions -5.77%-3.82%-1.87%

In the previous week, Evolent Health and Evolent Health both had 3 articles in the media. Evolent Health's average media sentiment score of 0.25 beat TIC Solutions' score of -0.19 indicating that Evolent Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evolent Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
TIC Solutions
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Evolent Health beats TIC Solutions on 7 of the 13 factors compared between the two stocks.

How does Evolent Health compare to Flywire?

Flywire (NASDAQ:FLYW) and Evolent Health (NYSE:EVH) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Flywire presently has a consensus target price of $18.07, indicating a potential upside of 14.02%. Evolent Health has a consensus target price of $6.08, indicating a potential upside of 35.49%. Given Evolent Health's higher possible upside, analysts clearly believe Evolent Health is more favorable than Flywire.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Flywire
0 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.73
Evolent Health
1 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.71

95.9% of Flywire shares are held by institutional investors. 5.0% of Flywire shares are held by company insiders. Comparatively, 1.5% of Evolent Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Flywire has a net margin of 4.45% compared to Evolent Health's net margin of -26.29%. Flywire's return on equity of 3.78% beat Evolent Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Flywire4.45% 3.78% 2.61%
Evolent Health -26.29%0.36%0.10%

In the previous week, Flywire had 7 more articles in the media than Evolent Health. MarketBeat recorded 10 mentions for Flywire and 3 mentions for Evolent Health. Flywire's average media sentiment score of 0.41 beat Evolent Health's score of 0.25 indicating that Flywire is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Flywire
5 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Evolent Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Flywire has higher earnings, but lower revenue than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Flywire, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Flywire$623.03M3.14$13.50M$0.2368.91
Evolent Health$1.88B0.27-$534.51M-$4.76N/A

Flywire has a beta of 1.34, indicating that its stock price is 34% more volatile than the broader market. Comparatively, Evolent Health has a beta of 0.84, indicating that its stock price is 16% less volatile than the broader market.

Summary

Flywire beats Evolent Health on 14 of the 17 factors compared between the two stocks.

How does Evolent Health compare to Stagwell?

Stagwell (NASDAQ:STGW) and Evolent Health (NYSE:EVH) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

Stagwell currently has a consensus price target of $7.65, suggesting a potential upside of 14.01%. Evolent Health has a consensus price target of $6.08, suggesting a potential upside of 35.49%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts clearly believe Evolent Health is more favorable than Stagwell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stagwell
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43
Evolent Health
1 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.71

Stagwell has a beta of 1.29, suggesting that its share price is 29% more volatile than the broader market. Comparatively, Evolent Health has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market.

Stagwell has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stagwell$2.91B0.57$29.10M$0.0795.86
Evolent Health$1.88B0.27-$534.51M-$4.76N/A

Stagwell has a net margin of 0.64% compared to Evolent Health's net margin of -26.29%. Stagwell's return on equity of 24.12% beat Evolent Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Stagwell0.64% 24.12% 4.31%
Evolent Health -26.29%0.36%0.10%

35.6% of Stagwell shares are owned by institutional investors. 11.2% of Stagwell shares are owned by insiders. Comparatively, 1.5% of Evolent Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Evolent Health had 2 more articles in the media than Stagwell. MarketBeat recorded 3 mentions for Evolent Health and 1 mentions for Stagwell. Evolent Health's average media sentiment score of 0.25 beat Stagwell's score of -0.30 indicating that Evolent Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stagwell
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Evolent Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Stagwell beats Evolent Health on 11 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Concentrix?

Evolent Health (NYSE:EVH) and Concentrix (NASDAQ:CNXC) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

Evolent Health currently has a consensus target price of $6.08, indicating a potential upside of 35.49%. Concentrix has a consensus target price of $48.50, indicating a potential upside of 93.42%. Given Concentrix's higher possible upside, analysts clearly believe Concentrix is more favorable than Evolent Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evolent Health
1 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.71
Concentrix
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Evolent Health has higher earnings, but lower revenue than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than Evolent Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evolent Health$1.88B0.27-$534.51M-$4.76N/A
Concentrix$9.83B0.16-$1.28B-$21.55N/A

90.3% of Concentrix shares are owned by institutional investors. 1.5% of Evolent Health shares are owned by company insiders. Comparatively, 0.9% of Concentrix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Evolent Health has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market. Comparatively, Concentrix has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market.

Concentrix has a net margin of -13.35% compared to Evolent Health's net margin of -26.29%. Concentrix's return on equity of 17.80% beat Evolent Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Evolent Health-26.29% 0.36% 0.10%
Concentrix -13.35%17.80%5.45%

In the previous week, Evolent Health had 1 more articles in the media than Concentrix. MarketBeat recorded 3 mentions for Evolent Health and 2 mentions for Concentrix. Concentrix's average media sentiment score of 1.66 beat Evolent Health's score of 0.25 indicating that Concentrix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evolent Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Concentrix
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Evolent Health beats Concentrix on 9 of the 16 factors compared between the two stocks.

Get Evolent Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVH vs. The Competition

MetricEvolent HealthINTERNET SOFTWARE IndustryComputer SectorNYSE Exchange
Market Cap$525.29M$16.35B$39.06B$23.14B
Dividend YieldN/A3.12%3.04%4.07%
P/E Ratio-0.9460.21172.2231.62
Price / Sales0.2743.30628.8822.79
Price / Cash0.9969.4447.9624.08
Price / Book1.276.259.744.68
Net Income-$534.51M$384.51M$1.07B$1.08B
7 Day Performance-1.90%-1.62%0.61%-0.26%
1 Month Performance15.44%-0.79%6.45%2.17%
1 Year Performance-48.05%-8.31%162.72%24.66%

Evolent Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVH
Evolent Health
2.8274 of 5 stars
$4.49
-4.0%
$6.08
+35.5%
-44.6%$525.29M$1.88BN/A4,200
ATHM
Autohome
2.8721 of 5 stars
$17.60
-1.4%
$17.15
-2.6%
-30.3%$2.06B$922.63M13.444,242
TIC
TIC Solutions
2.7999 of 5 stars
$8.47
+1.5%
$11.50
+35.9%
-27.4%$1.84B$1.53BN/A12,760
FLYW
Flywire
4.0453 of 5 stars
$14.71
-0.5%
$18.07
+22.9%
+42.9%$1.82B$623.03M63.961,400
STGW
Stagwell
3.8882 of 5 stars
$6.63
+1.1%
$7.65
+15.4%
+52.4%$1.63B$2.91B94.7112,629

Related Companies and Tools


This page (NYSE:EVH) was last updated on 6/18/2026 by MarketBeat.com Staff.
From Our Partners